Virtus Investment Advisers »

Ataibeckley shares owned by Virtus Investment Advisers

Quarter-by-quarter ownership of Ataibeckley (ATAI) shares owned by Virtus Investment Advisers from 13F filings

Historical chart of Virtus Investment Advisers investment in Ataibeckley

Tip: Access up to 7 years of quarterly data

All positions including Ataibeckley held by Virtus Investment Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ataibeckley by Virtus Investment Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $225k 64k 3.54

More positions owned by Virtus Investment Advisers

Gilead Sciences (GILD)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Immunitybio (IBRX)
Vertex Pharmaceuticals Incorporated (VRTX)
Incyte Corporation (INCY)
Vertiv Holdings Com Cl A (VRT)
Alnylam Pharmaceuticals (ALNY)
Edison International (EIX)
Ross Stores (ROST)
Quanta Services (PWR)
Day One Biopharmaceuticals I (DAWN)
Burlington Stores (BURL)
SLB Com Stk (SLB)
Merck & Co (MRK)

View all positions for Virtus Investment Advisers

Top funds holding Ataibeckley

Deep Track Capital
Vanguard Capital Management
UBS Group
BlackRock
Susquehanna International
Adage Capital Partners GP
Millennium Management
Morgan Stanley
Candriam Luxembourg S.C.A.
Qube Research & Technologies
Foresite Capital Management VI
Geode Capital Management
Marshall Wace
Rtw Investments
Two Sigma Investments

View all funds holding Ataibeckley